New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine - Rowan, A J; Ramsay, R E; Collins, J F; Pryor, F; Boardman, K D; Uthman, B M; Spitz, M; Frederick, T; Towne, A; Carter, G S; Marks, W; Felicetta, J; et al. (Neurology, 2005)
Keywords: Aged; Aging - physiology; Amines - administration & dosage; Amines - adverse effects; Amines - blood; Anticonvulsants - administration & dosage; Anticonvulsants - adverse effects; Anticonvulsants - blood; Carbamazepine - administration & dosage; Carbamazepine - adverse effects; Carbamazepine - blood; Cerebral Infarction - complications; Cyclohexanecarboxylic Acids - administration & dosage; Cyclohexanecarboxylic Acids - adverse effects; Cyclohexanecarboxylic Acids - blood; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsy - drug therapy; Epilepsy - epidemiology; Epilepsy - etiology; gamma-Aminobutyric Acid - administration & dosage; gamma-Aminobutyric Acid - adverse effects; gamma-Aminobutyric Acid - blood; Hospitals, Veterans - statistics & numerical data; Humans; Patient Compliance - statistics & numerical data; Patient Selection; Treatment Outcome; Triazines - administration & dosage; Triazines - adverse effects; Triazines - blood; United States; United States Department of Veterans Affairs - statistics & numerical data; United States